Stockscreener 앱 받기
1.68
0.60%
0.01
시간 외 거래:
1.73
0.05
+2.98%
전일 마감가:
$1.67
열려 있는:
$1.61
하루 거래량:
353.29K
Relative Volume:
0.11
시가총액:
$12.89M
수익:
$598.00K
순이익/손실:
$-44.93M
주가수익비율:
-0.2022
EPS:
-8.31
순현금흐름:
$-17.32M
1주 성능:
+34.40%
1개월 성능:
+40.59%
6개월 성능:
-44.69%
1년 성능:
-89.53%
1일 변동 폭
$1.61
$1.89
1주일 범위
$1.51
$2.8599
52주 변동 폭
$1.09
$18.00
Ernexa Therapeutics Inc Stock (ERNA) Company Profile
명칭
Ernexa Therapeutics Inc
전화
(617) 798-6700
주소
1035 CAMBRIDGE STREET, CAMBRIDGE
ERNA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ERNA
Ernexa Therapeutics Inc
|
1.68 | 12.81M | 598.00K | -44.93M | -17.32M | -8.31 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -906.14M | -6.1812 |
Ernexa Therapeutics Inc 주식(ERNA)의 최신 뉴스
Will breakout in Ernexa Therapeutics Inc. lead to full recoveryGap Up & Smart Allocation Stock Tips - newser.com
Ernexa Therapeutics Inc. stock chart pattern explainedJuly 2025 PreEarnings & High Accuracy Investment Entry Signals - newser.com
Risk vs reward if holding onto Ernexa Therapeutics Inc.Index Update & Low Volatility Stock Recommendations - newser.com
Will Ernexa Therapeutics Inc. bounce back from current supportQuarterly Trade Review & Capital Efficient Trading Techniques - newser.com
Should I hold or sell Ernexa Therapeutics Inc. stock in 2025Risk Management & High Conviction Trade Alerts - newser.com
Is it too late to sell Ernexa Therapeutics Inc.Portfolio Risk Summary & High Yield Equity Trading Tips - newser.com
Multi asset correlation models including Ernexa Therapeutics Inc.Market Movers & AI Optimized Trading Strategy Guides - newser.com
Why Ernexa Therapeutics Inc. stock is recommended by analystsLayoff News & Scalable Portfolio Growth Methods - newser.com
How strong is Ernexa Therapeutics Inc. stock revenue growthJuly 2025 Highlights & Free Risk Controlled Daily Trade Plans - newser.com
How Ernexa Therapeutics Inc. stock reacts to oil pricesJuly 2025 Outlook & Long Hold Capital Preservation Plans - newser.com
Sector ETF performance correlation with Ernexa Therapeutics Inc.Trade Entry Summary & Precise Buy Zone Identification - newser.com
Using data filters to optimize entry into Ernexa Therapeutics Inc.Weekly Trend Recap & Expert Curated Trade Setup Alerts - newser.com
Analyzing drawdowns of Ernexa Therapeutics Inc. with statistical toolsEarnings Recap Report & Verified Chart Pattern Signals - newser.com
Is Ernexa Therapeutics Inc. stock a buy in volatile marketsJuly 2025 Market Mood & Weekly Breakout Stock Alerts - newser.com
How to monitor Ernexa Therapeutics Inc. with trend dashboards2025 Year in Review & Stock Portfolio Risk Control - newser.com
Will Ernexa Therapeutics Inc. stock benefit from automationTrade Analysis Report & Fast Gain Stock Trading Tips - newser.com
Is Ernexa Therapeutics Inc. stock attractive for long term wealth buildingJuly 2025 Closing Moves & Verified Momentum Stock Ideas - newser.com
3 Penny Stocks to Watch Now, 10/30/25 - TipRanks
Ernexa Therapeutics (ERNA) Skyrockets on Cancer Therapy Deal – Will Rally Last? - ts2.tech
ERNA Stock Rallies On Collaboration With Contract Manufacturer To Advance Lead Cell Therapy Into Clinical Trials - Asianet Newsable
Cellipont Bioservices and Ernexa Therapeutics Enter Cell Therapy Manufacturing Partnership to Advance ERNA-101 Toward Clinical Trials in Ovarian Cancer - PR Newswire
/C O R R E C T I O N -- Cellipont Bioservices/ - Lelezard
Ernexa Therapeutics Inc (ERNA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.45%
0.86%
자본화:
|
볼륨(24시간):